Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Low immunogenic potential of tocilizumab in patients with rheumatoid arthritis: Analysis of four phase 3 clinical trials Ramos-Remus, C., Genovese, M. C., Harre, R. A., Woodworth, T., Alecock, E. WILEY-LISS. 2008: S534
View details for Web of Science ID 000259244201253